Ditchcarbon
  • Customers
  1. Organizations
  2. Molecular Partners AG
Public Profile
Pharmaceutical Preparation Manufacturing
CH
updated 5 months ago

Molecular Partners AG

Company website

Molecular Partners AG, a pioneering biotechnology company headquartered in Zurich, Switzerland (CH), is at the forefront of developing innovative therapies for serious diseases. Founded in 2004, the company has made significant strides in the field of protein therapeutics, particularly with its proprietary DARPins (Designed Ankyrin Repeat Proteins) technology, which offers unique advantages in specificity and stability. With a strong focus on oncology and infectious diseases, Molecular Partners has established itself as a key player in the biopharmaceutical industry. The company’s lead product candidates, including MP0310 and MP0420, showcase its commitment to addressing unmet medical needs through cutting-edge science. Recognised for its robust pipeline and strategic partnerships, Molecular Partners AG continues to enhance its market position, driving advancements in targeted therapies that promise to transform patient outcomes.

DitchCarbon Score

How does Molecular Partners AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

28

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Molecular Partners AG's score of 28 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.

38%

Let us know if this data was useful to you

Molecular Partners AG's reported carbon emissions

Molecular Partners AG, headquartered in Switzerland (CH), currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges at this time. As a result, there are no significant achievements or commitments to report regarding their climate initiatives. The absence of emissions data and reduction strategies suggests that Molecular Partners AG may still be in the early stages of developing a comprehensive climate action plan. In the context of the biotechnology industry, it is increasingly important for companies to adopt transparent climate commitments and set measurable targets to align with global sustainability goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Molecular Partners AG's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Molecular Partners AG is in CH, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Molecular Partners AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

MorphoSys

DE
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

DBV Technologies S.A.

FR
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Clinigen

GB
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

RECORDATI

LU
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Ablynx NV

BE
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Almirall

ES
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250807.4
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy